<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03753880</url>
  </required_header>
  <id_info>
    <org_study_id>MUV 1.0</org_study_id>
    <nct_id>NCT03753880</nct_id>
  </id_info>
  <brief_title>Hemopatch for Prevention of Bile Leaks After Liver Resection</brief_title>
  <official_title>Efficacy of NHS-PEG (Pentaerythirol Polyethylene Glycol Ether Tetra-succinimidyl Glutarate) Coated Collagen Patch (Hemopatch速) for Prevention of Bile Leaks After Liver Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In liver surgery bile leaks are still a major cause of postoperative morbidity with the need
      for additional diagnostic tests, additional interventions, prolonged hospital stay, mortality
      and higher costs. Efforts to further reduce the rate of postoperative biliary morbidity are
      therefore important.A new polyethylene glycol (PEG)-coated collagen pad (Hemopatch速) showed
      faster and more sustained hemostasis, less blood loss, and lower hematoma formation than the
      fibrin-coated collagen patch in an animal model. This might be attributed to an improved
      tissue adherence of the PEG-coated pad. We hypothesize that this strong adherence to the
      hepatic resection surface may also serve as a mechanical sealant of bile ducts thus
      preventing biliary leakage.

      To date, there exists no study including a sufficient number of patients to clarify whether
      sealing of the hepatic resection surface with Hemopatch速 can reduce the rate of biliary leaks
      and data regarding the expected difference in the incidence of biliary complications are
      lacking.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 23, 2019</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bile leaks</measure>
    <time_frame>30 days</time_frame>
    <description>biliary leak is defined as bilirubin concentration in the abdominal drain fluid at least 3 times the serum bilirubin concentration on or after postoperative day 3 or as the need for radiologic or operative intervention resulting from biliary collections or biliary peritonitis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bleeding</measure>
    <time_frame>30 days</time_frame>
    <description>Postoperative bleeding that requires surgical intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abscess</measure>
    <time_frame>30 days</time_frame>
    <description>Abscess that requires surgical intervention or percutaneous drainage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortalitiy</measure>
    <time_frame>30 days</time_frame>
    <description>Overall mortality within 30 days post liver resection</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">71</enrollment>
  <condition>Bile Leak</condition>
  <arm_group>
    <arm_group_label>Hemopatch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hemopatch used to cover the resection surface after LR</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HEMOPATCH Sealing Hemostat</intervention_name>
    <description>Hemopatch sealing hemostat used after LR to cover the resection surface</description>
    <arm_group_label>Hemopatch</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective hepatic resection

        Exclusion Criteria:

          -  Minor atypical hepatectomy without a plain cut surface

          -  Contraindications to the application of Hemopatch速
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christoph Schwarz, MD., PhD</last_name>
    <phone>0043(0)1/40400/56210</phone>
    <email>christoph.a.schwarz@meduniwien.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Schwarz, MD., PhD</last_name>
      <phone>0043(0)40400/56210</phone>
      <email>christoph.a.schwarz@meduniwien.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Klaus Kaczirek, MD.</last_name>
      <phone>0043(0)1/40400/56210</phone>
      <email>klaus.kaczirek@meduniwien.ac.at</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>November 19, 2018</study_first_submitted>
  <study_first_submitted_qc>November 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 27, 2018</study_first_posted>
  <last_update_submitted>October 23, 2019</last_update_submitted>
  <last_update_submitted_qc>October 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Christoph Schwarz</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Liver resection</keyword>
  <keyword>Bile leaks</keyword>
  <keyword>Outcome</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

